CTRI/2022/06/043136尚未招募2 期
Evaluation of Hepatoprotective Effect of Ayurvedic Medicine in Liver Cancer:A Single Arm Clinical Study
ational Institute of Ayurveda Jaipur0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 2 期
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. The patients between the age group of 30 to 70 years.
- •2. Known diagnosed cases of Liver cancer (primary & Secondary).
- •3. Patients willing to sign consent forms.
排除标准
- •Patients suffering from any kind of major systemic illness such as, MI, IHD, Hypertension, renal failure, tuberculosis, bronchial asthma and Diabetes etc.
- •Patients on radiotherapy and chemotherapy
研究者
相似试验
招募中
4 期
use of Aloevera in liver diseaseCTRI/2011/12/002284A100
尚未招募
3 期
Assessing the effect of Bilwadi Agada to protect the liver from alcohol damage A Clinical studyCTRI/2024/07/070631Sanjeevini Ayurveda Medical College and Hospital
已完成
3 期
Evaluation of hepatoprotective effect of picroliv in patients receiving multi drug therapy of tuberculosis.CTRI/2012/08/002850CSIR Central Drug research Institute260
已完成
3 期
Role of Chyawanprash in the prevention of COVID-19 in health care workersCTRI/2020/05/025275CCRAS New Delhi199
招募中
2 期
Comparative clinical study on Buras and Rohitaka in Liver DisorderCTRI/2017/11/010371ational Institute of Ayurveda Jaipur